Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
血液系统恶性肿瘤I期临床试验中5级毒性和疗效趋势:来自美国国家癌症研究所癌症治疗评估项目的20年经验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.02190
Chihara, Dai; Huang, Erich P; Finnigan, Shanda R; Cordes, Lisa M; Skorupan, Nebojsa; Fukuda, Yoko; Rubinstein, Larry V; Ivy, S Percy; Doroshow, James H; Nastoupil, Loretta J; Flowers, Christopher R; Takebe, Naoko